Welcure Drugs & Pharmaceuticals P/B Ratio
Welcure Drugs & Pharmaceuticals (WELCURE) P/B ratio is 0.28 (Low), book value per share ₹7.82 vs Healthcare average P/B of 0.01 — Very Low - Significant discount to book value, potential distress or value opportunity. Read WELCURE dividend yield for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
WELCURE P/B Ratio — Valuation Insights & Book Value Analysis
Welcure Drugs & Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 0.28 (Low). Explore WELCURE true value to estimate fundamental worth using multiple valuation models.
- Stock appears undervalued with PB of 0.28, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 93.7% below historical average
- Trading at premium to sector average PB of 0.01
Welcure Drugs & Pharmaceuticals P/B Ratio Historical Trend
WELCURE annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see WELCURE share price.
WELCURE Historical P/B Ratio — Book Value Per Share & Year-End Price
Welcure Drugs & Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.03 | ₹7.82 | ₹0.21 | ₹97 | Low |
| 2025 | 0.05 | ₹9.2 | ₹0.42 | ₹103 | Low |
| 2024 | 15.17 | ₹0.77 | ₹11.67 | ₹1 | High |
| 2023 | 2.5 | ₹1.54 | ₹3.85 | ₹2 | Moderate |
WELCURE vs Healthcare Peers — P/B Ratio Comparison
Welcure Drugs & Pharmaceuticals P/B 0.28 vs Healthcare average 0.01, median 0.67 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |